Evercore ISI Group Maintains In-Line on Inspire Medical Systems, Lowers Price Target to $60
Benzinga Newsdesk 6 hours ago
Analyst RatingsNewsPrice Target
Evercore ISI Group analyst Daniel Markowitz maintains Inspire Medical Systems (NYSE:INSP) with a In-Line and lowers the price target from $72 to $60.
Evercore ISI Group analyst Daniel Markowitz maintains Inspire Medical Systems (NYSE:INSP) with a In-Line and lowers the price target from $72 to $60.